Filing Details
MYRIAD GENETICS INC (NASDAQ:MYGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 31, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:MYGN
MYRIAD GENETICS INC (MYGN) Files Quarterly Report for Q0
Filing Details MYRIAD GENETICS INC (NASDAQ:MYGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 31, 2026. The Healthcare company…
Market Context
MYRIAD GENETICS INC's stock currently trades at $2.86 with a market capitalization of $680.9M.
The 10-Q provides MYRIAD GENETICS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for MYRIAD GENETICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MYGN Stock Page
Frequently Asked Questions
Where can I read MYGN's SEC filings?
Browse all filings on our MYGN SEC filings page.
What types of SEC filings does MYRIAD GENETICS INC file?
Public companies like MYRIAD GENETICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.